Skip to main content

Table 3 Tumor recurrence data

From: Influence of cirrhosis on long-term prognosis after surgery in patients with combined hepatocellular-cholangiocarcinoma

Variables Cirrhosis
n = 68
Non- cirrhosis
n = 35
P-value
Median time to recurrence, months 13 14 0.693
Recurrence type, n (%)
 Intrahepatic recurrence 42 (61.8) 24 (68.6) 0.495
 Extrahepatic recurrence 19 (27.9) 8 (22.8) 0.578
 Both 7 (10.3) 3 (8.6) 0.780
Treatment of recurrence, n (%)
 Aggressive approach 25 (36.8) 21 (60.0) 0.025
 Rehepatectomy 3 (4.3) 5 (14.3) 0.076
 Local ablation 22 (32.4) 16 (45.7) 0.183
 Transarterial chemoembolization 26 (38.2) 9 (25.7) 0.204
 Systemic chemotherapy 5 (7.4) 2 (5.7) 0.754
 Conservative treatment 12 (17.6) 3 (8.6) 0.216